Tag Archives: Xarelto

Featured Stories

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

Fracking Boom Changing Way of Life in Pennsylvania's Northern Tier

In just a few years, the impact of hydraulic fracturing (fracking) drilling on northeastern Pennsylvania is hard to miss. Thousands of natural gas wells have been opened in that area specifically in the last five years as companies look to exploit the vast Marcellus shale formation about two miles below the ...

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two Leading Cancer Groups Issue Call for Regulation of E-cigarettes and Research on Health Risks

In a joint statement, the American Society of Clinical Oncology and the American Association for Cancer Research have called on the federal government to move quickly to regulate e-cigarettes and increase research on their health effects. These leading research and treatment organizations asked the Food and Drug Administration (FDA) to make ...

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...
Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

Long Island Car Crash Kills 1 Person, Injures 2 More

Long Island Car Crash Kills 1 Person, Injures 2 More

A car accident on LI left one person dead & two more critically injured. The crash occurred Monday in Deer Park on Straight Path, south of Sagamore Lane.

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Xarelto Manufacturer Leads Spending for Physicians’ Favor

Xarelto Manufacturer Leads Spending for Physicians’ Favor

The public-interest news organization ProPublica issued a new report that indicates manufacturers spent more in 2015 on physician payments for Xarelto than any other drug. These payments were not for research, but for things like consulting, meals, travel, promotional speaking, … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Pretrial Proceedings Moving Forward in First Four Xarelto Bellwether Cases

Pretrial Moving Forward in First 4 Xarelto Bellwether Cases

In a recent court order, Judge Eldon Fallon, who oversees the Xarelto multidistrict litigation in the Eastern District of Louisiana, outlined the schedule for the first four trials. Judge Fallon has selected four cases to serve as the first bellwether … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Xarelto Plaintiffs Hope for Outcome Similar to Pradaxa Settlement

Xarelto Plaintiffs Hope for Similar Pradaxa Settlement

The current multidistrict litigation (MDL) comprised of more than 7,000 Xarelto (rivoxaban) lawsuits filed against the Johnson & Johnson subsidiary, Janssen Pharmaceuticals, and Bayer AG is being overseen by the Honorable Judge Eldon E. Fallon in the Eastern District of … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged , , , , , |

Xarelto Plaintiffs have More Time to File Lawsuits

Xarelto Plaintiffs have More Time to File Lawsuits

Due to the number of Xarelto lawsuits that have flooded the clerk’s office, Judge Eldon Fallon has extended the filing deadline by 90 days. There are more than 7,000 lawsuits pending in the multidistrict litigation in the Eastern District of … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

In Xarelto MDL, Judge Extends Deadline to File Complaints

In Xarelto MDL, Judge Extends Deadline to File Complaints

Certain groups of plaintiffs in the Xarelto multidistrict litigation (MDL) have more time to file a lawsuit against manufacturers Janssen Pharmaceuticals and Bayer Healthcare. According to a recent order issued by Judge Eldon Fallon, who is overseeing the MDL in … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , , , |

Quality of Xarelto Clinical Trials Expected to be an Issue in 2017 Court Cases

Xarelto Clinical Trials to be an Issue in 2017 Lawsuits

When the first lawsuits involving the blood-thinning drug Xarelto go to trial in 2017, attorneys expect the quality of the clinical trials involved in the drug’s approval to be a major issue. Xarelto lawsuits have been filed in both federal … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , , , , , , , |

Xarelto Lawsuits Continue to Mount, Clinical Trials Under Scrutiny

Xarelto Lawsuits Rise, Clinical Trials Under Scrutiny

According to court records, Bayer AG and Janssen Pharmaceuticals are facing close to 6,000 lawsuits alleging that the companies failed to warn about the risks associated with Xarelto, an anti-coagulant drug. Plaintiffs in the litigation allege that the blood thinner … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , , , , |

Bellwether Trial Dates in Xarelto Litigation Scheduled for 2017

Bellwether Trial Dates in Xarelto Suits Scheduled for 2017

Bellwether trial dates have been selected in the Xarelto multidistrict litigation (MDL) 2592. Court records show that more than 2,800 lawsuits have been consolidated into the MDL in Eastern Louisiana before U.S. District Judge Eldon E. Fallon. A list of … Continue reading

Posted in Legal News, Pharmaceuticals | Tagged , , , , , , , , |

Lawsuit Alleges Eliquis Caused Fatal Hemorrhaging, Drug Makers Failed to Warn

Pfizer and Bristol-Myers Squibb are facing a wrongful death lawsuit alleging that the companies failed to warn about the risk of irreversible bleeding with Eliquis (apixaban), an anticoagulant. The lawsuit was filed on behalf of a woman whose husband began … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , |

Xarelto Led to Uncontrollable, Fatal Bleeding, Lawsuit Alleges

Xarelto Led to Uncontrollable, Fatal Bleeding

A woman in Vermont has filed a lawsuit alleging that her father suffered a fatal, uncontrollable brain bleed after taking the anticoagulant Xarelto. The lawsuit alleges that Bayer AG and Janssen Pharmaceuticals failed to warn about the risk of irreversible … Continue reading

Posted in Pharmaceuticals | Tagged , , , |

© 2005-2020 Parker Waichman LLP ®. All Rights Reserved.